Myth-buster
A meta-analysis of resveratrol for type 2 diabetes found no significant effect on fasting blood sugar — and the same held for every other glycemic measure tested.
This is one of the first comprehensive reviews to challenge the popular idea that resveratrol meaningfully lowers blood sugar in people with type 2 diabetes, but the picture is now contested — not settled — because the underlying studies varied widely and had notable limitations.
Researchers pooled data from multiple clinical trials on resveratrol supplementation in people with type 2 diabetes and found no statistically significant improvement in fasting blood glucose, hemoglobin A1c, insulin levels, or insulin resistance. The only possible exception was a modest reduction in LDL cholesterol, but the authors concluded the overall evidence was too inconsistent and limited to recommend resveratrol for glycemic control.
Where this fits in the evidence
This is among the first studies we've indexed on Resveratrol for Reduced Fasting Blood Glucose Levels — treat it as an early signal until more research accumulates.
The study
- Meta-Analysis
- 2026-06-10
- Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.